Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: the PIONEER programme

TK Thethi, R Pratley, JJ Meier - Diabetes, Obesity and …, 2020 - Wiley Online Library
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are recommended for glycaemic
management in patients with type 2 diabetes (T2D). Oral semaglutide, the first oral GLP …
被引用次数：116 相关文章
[HTML] nih.gov

[HTML][HTML] Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme

TK Thethi, R Pratley, JJ Meier - Diabetes, Obesity & Metabolism, 2020 - ncbi.nlm.nih.gov
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are recommended for glycaemic
management in patients with type 2 diabetes (T2D). Oral semaglutide, the first oral GLP …

Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme.

TK Thethi, R Pratley, JJ Meier - Diabetes, Obesity & Metabolism, 2020 - europepmc.org
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are recommended for glycaemic
management in patients with type 2 diabetes (T2D). Oral semaglutide, the first oral GLP …

Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme

TK Thethi, R Pratley, JJ Meier - Diabetes, Obesity and Metabolism, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Glucagon‐like peptide‐1 receptor agonists
(GLP‐1RAs) are recommended for glycaemic management in patients with type 2 diabetes …

Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme

TK Thethi, R Pratley, JJ Meier - Diabetes, obesity & …, 2020 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are recommended for glycaemic
management in patients with type 2 diabetes (T2D). Oral semaglutide, the first oral GLP …

Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme.

TK Thethi, R Pratley, JJ Meier - Diabetes, Obesity & …, 2020 - search.ebscohost.com
Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are recommended for glycaemic
management in patients with type 2 diabetes (T2D). Oral semaglutide, the first oral GLP …